rs863224830
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_000179.3(MSH6):c.4081_4082delTA(p.Ter1361AspfsTer2) variant causes a frameshift, stop lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,457,708 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000179.3 frameshift, stop_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH6 | NM_000179.3 | c.4081_4082delTA | p.Ter1361AspfsTer2 | frameshift_variant, stop_lost | Exon 10 of 10 | ENST00000234420.11 | NP_000170.1 | |
FBXO11 | NM_001190274.2 | c.*1261_*1262delTA | downstream_gene_variant | ENST00000403359.8 | NP_001177203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH6 | ENST00000234420.11 | c.4081_4082delTA | p.Ter1361AspfsTer2 | frameshift_variant, stop_lost | Exon 10 of 10 | 1 | NM_000179.3 | ENSP00000234420.5 | ||
FBXO11 | ENST00000403359.8 | c.*1261_*1262delTA | downstream_gene_variant | 1 | NM_001190274.2 | ENSP00000384823.4 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 151872Hom.: 0 Cov.: 31 FAILED QC
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251044Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135712
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1457708Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 725424
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000658 AC: 1AN: 151872Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74170
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
- -
Stop codon loss and change to an aspartic acid codon, leading to protein extension and the addition of 1 amino acid at the C-terminus; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 36922933) -
Lynch syndrome Uncertain:1
This sequence change deletes 2 nucleotide from exon 10 of the MSH6 mRNA (c.4079_4080delTA). This deletion disrupts the translational stop signal of the MSH6 mRNA and it is expected to extend the length of the MSH6 protein by 2 additional amino acid residues (p.*1361Aspext*2). The effect of this extension on protein function is uncertain. This variant has not been published in the literature and is not present in population databases. In summary, this is a novel stop-loss variant with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This sequence change disrupts the translational stop signal of the MSH6 mRNA. It is expected to extend the length of the MSH6 protein by one additional amino acid residue. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MSH6-related conditions. -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.4081_4082delTA variant, located in coding exon 10 of the MSH6 gene, results from a deletion of two nucleotides at nucleotide positions 4081 to 4082, causing a translational frameshift with a predicted alternate stop codon (p.*1361Dext*1). This alteration occurs at the 3' terminus of theMSH6 gene, is not expected to trigger nonsense-mediated mRNAdecay and results in the elongation of the protein by one amino acid. The exact functional effect of the altered amino acids is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at